Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme

EXCLI Journal

Volumn 11, Issue , 2012, Pages 108-115

  Wanwimolruk, Sompon ^a   Prachayasittikul, Supaluk ^a   Prachayasittikul, Virapong ^a   Bernichi, Bouchra ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Cranberry; CYP3A4; Dietary supplements; Drug interactions

Indexed keywords

3 HYDROXY QUININE; CRAN BALANCE; CRAN RICH; CRANBERRY EXTRACT; CYTOCHROME P450 3A2; METHANOL; QUININE; QUININE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRANBERRY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HERB DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY;

EID: 84867605682     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abdul MIM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008;154: 1691-700.
2. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-10.
3. Blumenthal M. Herbs continue slide in mainstream market: sales down 14 percent. HerbalGram 2003;58:71.
4. Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med 1996;62:212-6.
5. Carmady B, Smith CA. Use of Chinese medicine by cancer patients: a review of surveys. Chin Med 2011;6:22.
6. Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survi-vors. Breast Cancer Res Treat 2009;116: 387-96.
7. Draves AH, Walker SE. Analysis of the hypericin and pseudohypericin content of commercially available St. John's wort preparations. Can J Clin Pharmacol 2003; 10:114-8.
8. Frankos VH, Street DA, O'Neill RK. FDA regulation of dietary supplements and re-quirements regarding adverse event report-ing. Clin Pharmacol Ther. 2010;87:239-44.
9. Greenblatt DJ, Patki KC, von Moltke LL, Shader RI. Drug interactions with grape-fruit juice: an update. J Clin Psychophar-macol 2001;21:357-9.
10. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in hu-mans. Clin Pharmacol Ther 2006;79:255-62.
11. Guay DR. Cranberry and urinary tract in-fections. Drugs 2009;69:775-807.
12. Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999;39:1-17.
13. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000;57:963-9.
14. Haber SL, Cauthon KA, Raney EC. Cran-berry and warfarin interaction: a case re-port and review of the literature. Consult Pharm 2012;27:58-65.
15. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73:1101-6.
16. Ho P-C, Ghose K, Saville DJ, Wanwimol-ruk S. Effect of grapefruit juice on phar-macokinetics and pharmacodynamics of verapamil enantiomers in healthy volun-teers. Eur J Clin Pharmacol 2000;56:693-8.
17. Howell AB. Bioactive compounds in cran-berries and their role in prevention of uri-nary tract infections. Mol Nutr Food Res 2007;51:732-7.
18. Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blue-berries in UTI prevention. Mol Nutr Food Res 2007;51:738-45.
19. Jiang B, Cai F, Gao S, Meng L, Liang F, Dai X, et al. Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components. Chem Biol Interact 2012;195: 105-13.
20. Kelly JP, Kaufman DW, Kelley K, Rosen-berg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-6.
21. Kim E, Sy-Cordero A, Graf TN, Brantley SJ, Paine MF, Oberlies NH. Isolation and identification of intestinal CYP3A inhi-bitors from cranberry (Vaccinium macro-carpon) using human intestinal micro-somes. Planta Med 2011;77:265-70.
22. Kim H, Yoon YJ, Shon JH, Cha IJ, Shin JG, Liu KH. Inhibitory effects of fruit juic-es on CYP3A activity. Drug Metab Dispos 2006;34:521-3.
23. Krenn L, Steitz M, Schlicht C, Kurth H, Gaedcke F. Anthocyanin-and proantho-cyanidin-rich extracts of berries in food supplements-analysis with problems. Pharmazie 2007;62:803-12.
24. Kresty LA, Howell AB, Baird M. Cranber-ry proanthocyanidins mediate growth ar-rest of lung cancer cells through modula-tion of gene expression and rapid induction of apoptosis. Molecules 2011;16:2375-90.
25. Lilja JJ, Backman JT, Neuvonen PJ. Ef-fects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine and midazolam-probes of CYP2C9, CYP1A2 and CYP3A4. Clin Pharmacol Ther 2007;81:833-9.
26. Lown KS, Bailey DG, Fontana RJ, Janar-dan SK, Adair CH, Fortlage LA, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intes-tinal CYP3A protein expression. J Clin Invest 1997;99:2545-53.
27. Lynch T, Price A. The effect of cyto-chrome P450 metabolism on drug re-sponse, interactions, and adverse effects. Am Fam Physician 2007;76:391-6.
28. Nassiri-Asl M, Hosseinzadeh H: Review of the pharmacological effects of Vitis vinif-era (Grape) and its bioactive compounds. Phytother Res 2009;23,1197-204.
29. Neto CC. Cranberries: ripe for more cancer research? J Sci Food Agric 2011;91:2303-7.
30. Pierce JP, Faerber S, Wright FA, Rock CL, Newman V, Flatt SW, et al. A randomized trial of the effect of plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) study. Control Clin Trials 2002;23:728-56.
31. Sanzini E, Badea M, Santos AD, Restani P, Sievers H. Quality control of plant food supplements. Food Funct 2011;2:740-6.
32. Shi S, Klotz U. Drug interactions with herbal medicines. Clin Pharmacokinet 2012;51:77-104.
33. Tindle HA, Davis RB, Phillips RS, Eisen-berg DM. Trends in use of complementary and alternative medicine by U.S. adults: 1997-2002. Altern Ther Health Med 2005; 11:42-9.
34. Uesawa Y, Mohri K. Effects of cranberry juice on nifedipine pharmacokinetics in rats. J Pharm Pharmacol 2006;58:1067-72.
35. Wanwimolruk S, Wong SM, Zhang H, Coville PF. Simultaneous determination of quinine and a major metabolite 3-hydroxy-quinine in biological fluids by HPLC with-out extraction. J Liquid Chromatogr 1996; 19:293-305.
36. Wanwimolruk S, Prachayasittikul V. Vari-able inhibitory effect of herbal supplements of different brands on human P450 CYP1A2. EXCLI J 2012;11:7-19.
37. Wargovich MJ. Colon cancer chemo-prevention with ginseng and other botani-cals. J Korean Med Sci 2001;16 Suppl: S81-S86.
38. Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S. Evidence for an involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol 1997;43:245-52.
39. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidins B5-3′-gallate as the most effective antioxi-dant constituent. Carcinogenesis 1999;20: 1737-45.
40. Zhou SF. Drugs behave as substrates, in-hibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9:310-22.
41. Zhou Y, Zhuang W, Hu W, Liu GJ, Wu TX, Wu XT. Consumption of large amounts of allium vegetables reduces risk for gastric cancer in a meta-analysis. Gas-troenterology 2011;141:80-9.